Covagen
Protein Therapeutics
Covagen AG develops protein-based therapeutics for the treatment of inflammatory diseases and cancer. Its products enable the isolation of high affinity protein-based binders called Fynomers, which changes the activity of target molecules relevant...Founded in 2007
Homepage: http://www.covagen.com/
Total money raised: $40.5M
8057
Y17 M22, Life Science ETH/Uni
Winterthurerstrasse 190
Zürich
CHE
Winterthurerstrasse 190
Zürich
CHE
Phone: 41(0)44 635 60 33
Updated on Nov 29, 2010
Covagen at CrunchBase
Covagen at CrunchBase
November, 2010
Covagen raised $6.3M in a Series A round from Seroba Kernel, Edmond de Rothschild Venture Capital, MP Healthcare Venture Management, Novartis Venture Funds, and Ventech
Covagen closes Series A financing round with Seroba Kernel as lead investor 
covagen.com
December, 2009
Covagen raised $34.2M in a Series A round from Ventech
Covagen Extends Seed Funds, Plans For $34M Series A 
fis.dowjones.com
October, 2009
Covagen raised unknown amount in seed round from MP Healthcare Venture Management and Novartis Venture Fund
Covagen covagen.com
January, 2007
Covagen was founded on January, 2007